A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study

The purpose of this study was to evaluate the maximum tolerated dose (MTD) and recommended dose of oxaliplatin given synchronously with 5-fluorouracil (5FU), leucovorin (LV) and preoperative pelvic radiation for primary unresectable, locally advanced, rectal cancer. Preoperative pelvic radiotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Sebag-Montefiore, D, Glynne-Jones, R, Falk, S, Meadows, H M, Maughan, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361684/
https://www.ncbi.nlm.nih.gov/pubmed/16249791
http://dx.doi.org/10.1038/sj.bjc.6602818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361684/
https://www.ncbi.nlm.nih.gov/pubmed/16249791
http://dx.doi.org/10.1038/sj.bjc.6602818

Ejemplares similares